Scotia Capital Inc. 23and Me Holding Co. Transaction History

Scotia Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$2.19 - $3.98 $15 - $27	7 Added 0.05%	12,800 $32,000
Q1 2022 May 09, 2022	BUY	$3.28 - $7.12 $1,617 - $3,510	493 Added 4.01%	12,793 $49,000
Q4 2021 Feb 11, 2022	BUY	$6.55 - $13.25 $12,110 - $24,499	1,849 Added 17.69%	12,300 $82,000
Q3 2021 Nov 12, 2021	SELL	$7.29 - $11.0 $6,189 - $9,339	-849 Reduced 7.51%	10,451 $95,000
Q2 2021 Aug 12, 2021	BUY	$9.87 - $13.32 $111,530 - $150,516	11,300 New	11,300 $132,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $823M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.